Inflammatory Lesions
Triple-combination topical outperforms dyad formulations, improving acne within 4 weeks
Clindamycin phosphate 1.2%, adapalene 0.15% and benzoyl peroxide 3.1% triple-combination topical surpassed dyad formulations in speed of efficacy for acne, according to a study.
TheraClearX improves mild to moderate acne in all skin types
The TheraClearX Acne device was efficacious in reducing mild to moderate acne in all skin types, according to a study.
Triple-combination gel treatment for acne demonstrates efficacy, safety across age groups
Fixed-dose clindamycin phosphate 1.2%, adapalene 0.15% and benzoyl peroxide 3.1% gel demonstrated safety and efficacy across all age groups for the treatment of acne, according to a post hoc analysis.
Novel silymarin serum reduces effects of environmental oxidative stress, improves acne
A serum comprised of silymarin, an antioxidant derived from milk thistle plant seeds, improved the signs and symptoms of acne and acne treatment, according to a study.
Fixed-dose IDP-126 demonstrates fast-acting relief, sustained clearance for acne
Fixed-dose clindamycin phosphate 1.2%, adapalene 0.15% and benzoyl peroxide 3.1% gel achieved faster-acting efficacy than dyads and vehicle, according to a study.